Mouse Interleukin 17A, IL-17A ELISA Kit

SKU: E1143Mo

Size:96 Tests-1 Kit

Background:Effector cytokine of innate and adaptive immune system involved in antimicrobial host defense and maintenance of tissue integrity (PubMed: 18025225, PubMed: 19144317, PubMed: 26431948). Signals via IL17RA-IL17RC heterodimeric receptor complex, triggering homotypic interaction of IL17RA and IL17RC chains with TRAF3IP2 adapter. This leads to downstream TRAF6-mediated activation of NF-kappa-B and MAPkinase pathways ultimately resulting in transcriptional activation of cytokines, chemokines, antimicrobial Peptides and Matrix Metalloproteinases, with potential strong immune inflammation (PubMed: 17911633, PubMed: 16200068, PubMed: 19144317, PubMed: 26431948). Plays an important role in connecting T cell-mediated adaptive immunity and acute inflammatory response to destroy extracellular bacteria and fungi. As a signature effector cytokine of T-helper 17 cells (Th17), primarily induces neutrophil activation and recruitment at infection and inflammatory sites (PubMed: 18025225). In airway epithelium, mediates neutrophil chemotaxis via induction of CXCL1 and CXCL5 chemokines (PubMed: 18025225, PubMed: 27923703). In secondary lymphoid organs, contributes to germinal center formation by regulating the chemotactic response of B cells to CXCL12 and CXCL13, enhancing retention of B cells within the germinal centers, B cell somatic hypermutation rate and selection toward plasma cells (PubMed: 18157131). Effector cytokine of a subset of gamma-delta T cells that functions as part of an inflammatory circuit downstream IL1B, TLR2 and IL23A-IL12B to promote neutrophil recruitment for efficient bacterial clearance (PubMed: 17372004, PubMed: 20364087, PubMed: 28709803). Effector cytokine of innate immune cells including invariant natural killer cell (iNKT) and group 3 innate lymphoid cells that mediate initial neutrophilic inflammation (PubMed: 17470641, PubMed: 23255360). Involved in the maintenance of the integrity of epithelial barriers during homeostasis and pathogen infection. Upon acute injury, has a direct role in epithelial barrier formation by regulating OCLN localization and tight junction biogenesis (PubMed: 26431948). As part of the mucosal immune response induced by commensal bacteria, enhances host's ability to resist pathogenic bacterial and fungal infections by promoting neutrophil recruitment and antimicrobial Peptides release (PubMed: 28709803). In synergy with IL17F, mediates the production of antimicrobial beta-defensins DEFB1, DEFB103A, and DEFB104A by mucosal epithelial cells, limiting the entry of microbes through the epithelial barriers (PubMed: 19144317). Involved in antiviral host defense through various mechanisms (PubMed: 21946434, PubMed: 26735852, PubMed: 27795421). Enhances immunity against West Nile virus by promoting T cell cytotoxicity (PubMed: 27795421). May play a beneficial role in influenza A virus (H5N1) infection by enhancing B cell recruitment and immune response in the lung (PubMed: 21946434). Contributes to influenza A virus (H1N1) clearance by driving the differentiation of B-1a B cells, providing for production of virus-specific IgM antibodies at first line of host defense (PubMed: 26735852).

Research_area:Immunology

Applications:ELISA

Target_protein:IL17A

Reactivity:Mouse

Assay type:Sandwich

Sensitivity:0.97ng/L

Detection range:2-600ng/L

Sample type:Serum, plasma or other biological fluids

Full product name:Interleukin 17A

Species:Mouse

Storage:2-8ºC

Assay time:1h 30m

UniProt accession:Q62386

MASS(Da):17,490

GeneID:16171

Synonyms:CTLA-8;Cytotoxic T-lymphocyte-associated antigen 8;IL 17A;IL-17;IL17A;IL-17A;Interleukin-17A

Gene names:IL17A

Standard solution:800ng/L